Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
University of Birmingham and BAM extend research MoU - focused on chemistry and materials, energy, AM, and environmental and life sciences.